<code id='386F52C539'></code><style id='386F52C539'></style>
    • <acronym id='386F52C539'></acronym>
      <center id='386F52C539'><center id='386F52C539'><tfoot id='386F52C539'></tfoot></center><abbr id='386F52C539'><dir id='386F52C539'><tfoot id='386F52C539'></tfoot><noframes id='386F52C539'>

    • <optgroup id='386F52C539'><strike id='386F52C539'><sup id='386F52C539'></sup></strike><code id='386F52C539'></code></optgroup>
        1. <b id='386F52C539'><label id='386F52C539'><select id='386F52C539'><dt id='386F52C539'><span id='386F52C539'></span></dt></select></label></b><u id='386F52C539'></u>
          <i id='386F52C539'><strike id='386F52C539'><tt id='386F52C539'><pre id='386F52C539'></pre></tt></strike></i>

          entertainment

          entertainment

          author:comprehensive    Page View:1
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          FDA approves first new drug developed for postpartum depression
          FDA approves first new drug developed for postpartum depression

          AdobeTheFoodandDrugAdministrationonTuesdayapprovedbrexanolone,thefirstdrugspecificallytargetedtotrea

          read more
          DIEP, the 'gold standard' of breast reconstruction, is under threat
          DIEP, the 'gold standard' of breast reconstruction, is under threat

          AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

          read more

          Is mRNA technology the right fit for flu shots? Experts aren’t so sure

          MollyFergusonforSTATHerearetwothingsthataretrue.Theworldneedsmoreeffectivefluvaccines.Andpharmaceuti